Ensysce Biosciences Secures $60 Million Capital Commitment From Global Emerging Markets
Ensyce Biosciences notes under the accord, GEM agrees to provide Ensysce with a share subscription facility of up to $60 million for a 36-month term following the public listing of the Company's common stock.
Therapeutic Solutions International Launches Campbell Neurosciences: 1st Suicide Focused Regenerative Psychiatry Biotechnology Company
December 31, 2020
Therapeutic Solutions International, Inc., has announced the launching of Campbell Neurosciences Inc as a partially owned spin-off from the Company.
Therapeutic Solutions notes...
Jennifer Martin and Dan Rogers Added to the Omnia Medical Team: Martin to Lead the Interventional Pain Therapies Division Alongside Thomas Batton and Dan...
The launch of the new division comes at a critical time when providers are increasingly focused on delivering a more comprehensive range of therapies.
Micro-Tech Endoscopy and Interscope Announce Partnership & Extended FDA Clearance for EndoRotor® System
This extended clearance makes the EndoRotor the first FDA-cleared device used in DEN for WOPN/WON.
Cryoanalgesia and Non-Opioid Options Are Changing the Way We Manage Pain. Expert Shares His Views
As a specialist in Physical Medicine and Rehabilitation, I strive to help patients improve their function and pain. Therefore, it is paramount that I’m consistently well-informed of the latest clinical research and innovations within my field.